A trial of statin primary prevention in HIV has been discontinued for efficacy
An international clinical trial testing statin therapy for the primary prevention of cardiovascular disease in people with early HIV was discontinued because of strong evidence of efficacy and safety in this population. A planned interim analysis of data from the REPRIEVE study showed that a daily dose of pitavastatin reduced the risk of adverse cardiovascular … Read more